Arthrofitness Hospital For Joint Disease New York City, NY - 10016

Arthrofitness Hospital For Joint Disease is categorized under Doctors in New York City, NY and active since 2001.

Arthrofitness Hospital For Joint Disease was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Lori Cicale at the company’s single location by writing to 614 2nd Avenue Front, New York City, New York NY 10016 or by phoning (212) 684-3206. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Arthrofitness Hospital For Joint Disease
Contact Person: Lori Cicale
Address: 614 2nd Avenue Front, New York City, New York 10016
Phone Number: (212) 684-3206
Annual Revenue (USD): $100.000 to $499.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Arthrofitness Hospital For Joint Disease was started in 2001 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Lori Cicale for inquiries that concern Arthrofitness Hospital For Joint Disease by calling the company number (212) 684-3206, as your correspondence is most welcome. Additionally, the physical location of the single location of Arthrofitness Hospital For Joint Disease can be found at the coordinates as well as the street address 614 2nd Avenue Front in New York City, New York 10016.

For its online presence, you may visit Arthrofitness Hospital For Joint Disease’s website at and engage with its social media outlets through on Twitter and on Facebook.